The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
California Institute for Regenerative Medicine · Institute for Stem Cell Biology and Regenerative Medicine · +7 more institutions
Abstract
CD47, a "don't eat me" signal for phagocytic cells, is expressed on the surface of all human solid tumor cells. Analysis of patient tumor and matched adjacent normal (nontumor) tissue revealed that CD47 is overexpressed on cancer cells. CD47 mRNA expression levels correlated with a decreased probability of survival for multiple types of cancer. CD47 is a ligand for SIRPα, a protein expressed on macrophages and dendritic cells. In vitro, blockade of CD47 signaling using targeted monoclonal antibodies enabled macrophage phagocytosis of tumor cells that were otherwise protected. Administration of anti-CD47 antibodies inhibited tumor growth in orthotopic immunodeficient mouse xenotransplantation models established…
Citation impact
- FWCI
- 22.84
- Percentile
- 100%
- References
- 48
Authors
44- SBStephen B. WillinghamCorresponding
California Institute for Regenerative Medicine, Institute for Stem Cell Biology and Regenerative Medicine
- JVJens-Peter Volkmer
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
- AJAndrew J. Gentles
Center for Systems Biology
- DSDebashis Sahoo
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
- PDPiero Dalerba
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
Topics & keywords
- CD47
- Cancer research
- Phagocytosis
- Immune system
- Cancer cell
- Cancer
- Macrophage
- Antibody
- Good health and well-being